Chongqing Zhifei Biological Products Co.Ltd(300122) 3 announced on March 14 that Jiang Rensheng, the controlling shareholder of the company, reduced his holdings of 28.78 million non tradable shares of the company through block trading, accounting for 1.8% of the total share capital of the company, and the transferee is the company’s employee stock ownership plan (2022), that is, the third employee stock ownership plan since the listing of the company. After the transfer, Jiang Rensheng’s shareholding ratio decreased from 50.11% to 48.32%, and he is still the controlling shareholder of the company; The total shareholding ratio of Jiang Rensheng and those acting in concert still reached 54.42%.
It is reported that Chongqing Zhifei Biological Products Co.Ltd(300122) announced on January 28 this year that it plans to launch the draft employee stock ownership plan for common prosperity of the company (2022) to no more than 2000 employees, including 14 directors, supervisors and senior executives, raising no more than 1.6 billion yuan. It plans to raise funds in a ratio of no more than 1:1 through legal and compliance methods, and entrust professional institutions to manage it after establishment, The upper limit of the management scale is 3.2 billion yuan. It is planned to obtain shares through secondary market purchase (including but not limited to centralized bidding and block trading), with a duration of 48 months.
It is worth noting that the stock source of the company’s phase II ESOP is still transferred by Jiang Rensheng through block trading. At that time, the transfer price was about 10% of the market price. According to the calculation of 10% discount of Chongqing Zhifei Biological Products Co.Ltd(300122) closing price of 120.15 yuan / share on March 14, the cost price of the company’s ESOP warehouse building is about 108.14 yuan / share, with a total warehouse building amount of about 3.112 billion yuan, accounting for 97.25% of the upper limit of the management scale of the plan.
Chongqing Zhifei Biological Products Co.Ltd(300122) said that ESOP can effectively promote the company to implement long-term and stable talent development strategy, highlight the concept of common and sustainable development of the company and individuals, and mobilize the enthusiasm of managers and employees; Under the background of common prosperity, actively promote the balance between shareholders’ interests and employees’ interests and common prosperity.
The latest performance express shows that in 2021, the company achieved an operating revenue of 30.637 billion yuan, a year-on-year increase of 101.68%; The net profit attributable to the parent company was 10.197 billion yuan, an increase of 208.88%, and the earnings per share was 6.3731 yuan.
